— Know what they know.
Not Investment Advice
Also trades as: PREV.CN (CNQ) · $vol 0M

PRVCF OTC

PreveCeutical Medical Inc.
1W: -42.8% 1M: -41.1% 3M: -22.3% YTD: -41.8% 1Y: -56.2% 3Y: -46.4% 5Y: -48.5%
$0.01
+0.00 (+0.00%)
 
OTC · Healthcare · Biotechnology · Tech Score Sell · Power 41 · $6.2M mcap · 402M float · 0.0079% daily turnover · Short 57% of daily vol

Balance Sheet Trends

Total Assets
$226K +24.3% ▲
5Y CAGR: -23.4%
Total Liabilities
$7M +15.1% ▲
5Y CAGR: +5.1%
Shareholders Equity
-$7M -14.9% ▼
Cash & Investments
$59K +4029.8% ▲
5Y CAGR: +15.7%
Total Debt
$4M +14.5% ▲
5Y CAGR: -1.2%
Net Debt
$4M +13.1% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2020FY2021FY2022FY2023FY2024
— Assets —
Cash$156K$16K$6K$1K$59K
Short-Term Investments$0$0$0$0$0
Cash & ST Investments$156K$16K$6K$1K$59K
Net Receivables$91K$55K$19K$5K$27K
Inventory$0$0$0$0$0
Other Current Assets$0$0$0$0$0
Total Current Assets$263K$83K$63K$64K$117K
Property, Plant & Equip.$9K$2K$1K$961$2K
Goodwill & Intangibles$25K$76K$125K$117K$106K
Long-Term Investments$0$0$0$0$0
Other Non-Current Assets$6K$0$0$0$0
Total Non-Current Assets$39K$79K$126K$118K$109K
Total Assets$302K$161K$189K$182K$226K
— Liabilities —
Accounts Payable$145K$383K$371K$579K$911K
Short-Term Debt$1M$1M$3M$4M$4M
Deferred Revenue$0$0$0$0$0
Other Current Liabilities$0$953K$0$1M$1M
Total Current Liabilities$2M$3M$5M$6M$7M
Long-Term Debt$2M$2M$0$0$63K
Other Non-Current Liab.$0$0$0$0$0
Total Non-Current Liabilities$2M$2M$0$0$63K
Total Liabilities$4M$4M$5M$6M$7M
— Equity —
Common Stock$18M$19M$19M$19M$20M
Retained Earnings-$27M-$29M-$27M-$28M-$30M
Accumulated OCI$902K$1M$3M$2M$2M
Total Stockholders Equity-$4M-$4M-$5M-$6M-$7M
Total Liabilities & Equity$302K$161K$189K$182K$226K
— Key Metrics —
Total Debt$3M$3M$3M$4M$4M
Net Debt$3M$3M$3M$4M$4M
Total Investments$0$0$0$0$0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms